MedDataX Logo

Evaluation of Hospitalization for Anorexia Nervosa (EVALuation de l'Apport de l'HOSPITalisation Pour Anorexie Mentale : EVALHOSPITAM)

NCT ID: NCT00910169

Last Updated: 2012-08-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-03-31

Study Completion Date

2012-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this research is to evaluate the efficacy of five different in-patient treatment modalities and predictive factors of outcome for anorexia nervosa. The primary hypothesis is that the different treatment types impact outcome of patients at discharge from inpatient treatment and at one year follow-up, even after adjustment for confounding factors (age, length of illness, number of previous hospitalizations, clinical state at intake).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will evaluate global, psychiatric, somatic and psychosocial outcome for inpatients with anorexia nervosa through three evaluations (intake, discharge and one-year follow-up). The study will also consider five types of in-patient treatment in a naturalistic setting (i.e., patients will not be assigned to different treatment conditions; rather, we will study inpatient care as it exists today). The five treatment modalities to be studied are:

1. Discharge weight objectives.
2. The practice of a separation period.
3. The use of clear nutritional and dietary objectives (cognitive/behavioural).
4. The intensity of family involvement in treatment.
5. Stabilisation phase before ending inpatient treatment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anorexia Nervosa

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Anorexia nervosa treatment inpatient efficacy outcome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

inpatient treatment

naturalistic treatment no modification: observational study

inpatient treatment

Intervention Type OTHER

Hospitalisation modalities are described but are naturalistic

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

inpatient treatment

Hospitalisation modalities are described but are naturalistic

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

naturalistic treatment

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients who accept participation between 8 and 50 years old, consecutively hospitalized for a DSM IV diagnosis of Anorexia Nervosa in one of the departments participating in this research by necessity of physical condition (BMI \< 15, rapid weight loss) or psychological condition
* Parents of participating patients still living with their parents who accept participation

Exclusion Criteria

* Refusal of research
* Patients who do not speak French
* Patients with a related somatic illness (diabetes, Crohn's disease, metabolic illness)
* Patients not covered by social security health insurance
Minimum Eligible Age

8 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

Sponsor Role collaborator

Ministry of Health, France

OTHER_GOV

Sponsor Role collaborator

National Research Agency, France

OTHER

Sponsor Role collaborator

National Health Insurance Fund

OTHER

Sponsor Role collaborator

Fondation de la Mutuelle Générale de l'Education Nationale

UNKNOWN

Sponsor Role collaborator

Fondation de France

OTHER

Sponsor Role collaborator

Institut Mutualiste Montsouris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Institut Mutualiste Montsouris

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Godart Nathalie, PhD

Role: PRINCIPAL_INVESTIGATOR

INSERM and Institut Mutualiste Montsouris

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Insitut Mutualiste Montsouris

Paris, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Duclos J, Piva G, Riquin E, Lalanne C, Meilleur D, Blondin S; EVHAN Group; Cook-Darzens S, Godart N. Caregivers in anorexia nervosa: is grief underlying parental burden? Eat Weight Disord. 2023 Feb 20;28(1):16. doi: 10.1007/s40519-023-01530-x.

Reference Type DERIVED
PMID: 36807834 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ANR-0-JC0719-6328

Identifier Type: -

Identifier Source: secondary_id

PHRC AOM 06 020

Identifier Type: -

Identifier Source: secondary_id

Eudract: 2007 -A01110-53

Identifier Type: -

Identifier Source: org_study_id